Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Registry of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver With HepaSphere™ Microspheres Loaded With Irinotecan

NCT04866290 is registered in ClinicalTrials.gov with Merit Medical Systems, Inc. as lead sponsor.

NCT NCT04866290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04866290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Registry of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver With HepaSphere™ Microspheres Loaded With Irinotecan
Lead sponsor
Merit Medical Systems, Inc.
Phase
Observational
Overall status
Completed
Start date
September 22, 2016
Completion date
June 30, 2021
Enrollment
105 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer